Weight Loss

Weight Loss Medication Insurance Coverage: What's Covered in 2025?

By Dr. Rachel Gougian, DO, FAAFP, D-ABOM

Updated September 2026

Insurance coverage for weight loss medications is one of the most common questions patients ask before scheduling their first appointment. The answer is not simple, and it changes from year to year as insurance companies update their formularies and coverage policies.

This guide covers which medications are most likely to be covered, how prior authorization works, what to do if you are denied, and why paying out of pocket is a legitimate option for patients who want to skip the insurance process entirely.

GLP-1 medications like Wegovy, Ozempic, Mounjaro, and Zepbound are prescribed for weight management and for type 2 diabetes. Coverage depends heavily on which condition the medication is prescribed for and which insurance plan you have.

When these medications are prescribed for diabetes, coverage is significantly more common. Most commercial insurance plans, Medicare Part D plans, and Medicaid programs cover semaglutide (Ozempic) and tirzepatide (Mounjaro) for type 2 diabetes because they are considered standard-of-care treatments.

When the same medications are prescribed for weight loss, coverage varies widely. Wegovy (semaglutide for weight management) and Zepbound (tirzepatide for weight management) are the FDA-approved versions for obesity treatment. Some insurance plans cover them, but many do not, and those that do typically require prior authorization.

Coverage varies not only by insurer but by specific plan within each insurer. The information below reflects general trends as of 2025, but your individual coverage depends on the details of your plan. We always recommend calling the number on the back of your insurance card to confirm before starting treatment.

Commercial insurance (United Healthcare, Aetna, Cigna, Blue Cross, CareFirst, Anthem)

Many employer-sponsored plans now include some form of weight loss medication coverage, though it often requires prior authorization and documentation of previous weight loss attempts. Some plans cover Wegovy or Zepbound on their formulary, while others exclude weight loss medications entirely. CareFirst and Anthem plans in Maryland have been expanding coverage in recent years, but plan-level variation remains significant.

Medicare

Historically, Medicare has not covered weight loss medications. However, recent legislative changes have expanded Medicare coverage for anti-obesity medications in certain circumstances. As of 2025, Medicare Part D plans may cover FDA-approved weight loss medications for beneficiaries with a BMI of 30 or above, or 27 with a weight-related condition. Coverage details depend on your specific Part D plan.

Maryland Medicaid

Maryland Medicaid coverage for weight loss medications is limited and varies by managed care organization. Some plans provide coverage with prior authorization, while others do not include these medications in their formulary. We can help you determine what your specific Medicaid plan covers.

Prior authorization is the process of getting your insurance company's approval before they will cover a medication. For weight loss medications, the insurance company typically requires documentation that you meet certain criteria. These often include a BMI above a specific threshold, documentation of at least one obesity-related condition (such as high blood pressure, type 2 diabetes, or sleep apnea), and evidence that you have tried and failed other weight loss approaches.

The process usually takes one to two weeks, though it can take longer if additional information is requested. At Pandora Family Medicine, we handle the prior authorization paperwork for you. We submit the clinical documentation, respond to insurance requests for additional information, and follow up on pending authorizations. You do not need to navigate this process on your own.

This is one of the things that makes working with a physician's office different from a telehealth subscription service. When prior authorization is denied, we know how to appeal, and we have the clinical documentation to support it.

A denial does not always mean the answer is final. Insurance companies deny prior authorizations for weight loss medications frequently, sometimes for administrative reasons rather than clinical ones. Common reasons include missing documentation, using the wrong diagnosis code, or the medication not being on the plan's preferred drug list.

The first step after a denial is to review the reason. We can often resolve the issue by submitting additional documentation or correcting the submission. If the denial is upheld, a formal appeal is the next option. This sometimes involves a peer-to-peer review, where your doctor speaks directly with the insurance company's medical reviewer to make the clinical case for the medication.

We have successfully overturned denials for patients through this process. It takes time and effort, but for patients who want to use their insurance benefits, it is worth pursuing.

Some patients prefer to skip the insurance process entirely and pay out of pocket. This is a reasonable choice, and we support it without judgment.

At Pandora Family Medicine, the initial weight loss visit is $200. Follow-up visits are $150. There is no subscription fee, no monthly platform charge, and no mandatory program enrollment. You pay for the visit, not a membership. The medication itself is a separate cost, and we can help you find the best pricing through manufacturer coupons, pharmacy discount programs, or specialty pharmacies.

For patients who have been quoted four-figure monthly costs through telehealth platforms, the out-of-pocket pricing at a physician's office is often surprisingly affordable. The key difference is that you are paying for the medical care directly rather than subsidizing a technology platform.